4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-21-028453
Chief Financial Officer sold 87,339 shares at an average $26.45 ($2,310,106)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ruffo Frank Chief Financial Officer | 2021-04-22 | Sale | −30,000 | $26.84 | $805,218 | 209,059 | D |
| Ruffo Frank Chief Financial Officer | 2021-04-23 | Sale | −29,200 | $26.64 | $777,797 | 179,859 | D |
| Ruffo Frank Chief Financial Officer | 2021-04-23 | Sale | −800 | $27.33 | $21,863 | 179,059 | D |
| Ruffo Frank Chief Financial Officer | 2021-04-26 | Sale | −27,239 | $25.79 | $702,584 | 151,820 | D |
| Ruffo Frank Chief Financial Officer | 2021-04-26 | Sale | −100 | $26.44 | $2,644 | 151,720 | D |
| Open-market sales · 87,339 sh · avg $26.45 · $2,310,106 | |||||||
Loading xslF345X03/doc4.xml…